Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Jan;55(1):75–76. doi: 10.1038/bjc.1987.15

Lymphocytopenia as an independent predictor of early recurrence in breast cancer.

C W Pattison, K L Woods, J M Morrison
PMCID: PMC2001556  PMID: 3814479

Full text

PDF
75

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler A., Stein J. A., Ben-Efraim S. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease. Cancer. 1980 Apr 15;45(8):2074–2083. doi: 10.1002/1097-0142(19800415)45:8<2074::aid-cncr2820450814>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  2. Bloom H. J., Richardson W. W., Field J. R. Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J. 1970 Jul 25;3(5716):181–188. doi: 10.1136/bmj.3.5716.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Feehally J., Beattie T. J., Brenchley P. E., Coupes B. M., Houston I. B., Mallick N. P., Postlethwaite R. J. Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. N Engl J Med. 1984 Feb 16;310(7):415–420. doi: 10.1056/NEJM198402163100702. [DOI] [PubMed] [Google Scholar]
  4. Hamlin I. M. Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer. 1968 Sep;22(3):383–401. doi: 10.1038/bjc.1968.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mouridsen H. T., Palshof T. Adjuvant systemic therapy in breast cancer; a review. Eur J Cancer Clin Oncol. 1983 Dec;19(12):1753–1770. doi: 10.1016/0277-5379(83)90164-5. [DOI] [PubMed] [Google Scholar]
  6. Ownby H. E., Roi L. D., Isenberg R. R., Brennan M. J. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer. 1983 Jul 1;52(1):126–130. doi: 10.1002/1097-0142(19830701)52:1<126::aid-cncr2820520123>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  7. Papatestas A. E., Lesnick G. J., Genkins G., Aufses A. H., Jr The prognostic significance of peripheral lymphocyte counts in patients with breast carcinoma. Cancer. 1976 Jan;37(1):164–168. doi: 10.1002/1097-0142(197601)37:1<164::aid-cncr2820370123>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  8. Underwood J. C. Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer. 1974 Dec;30(6):538–548. doi: 10.1038/bjc.1974.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Whitwell H. L., Hughes H. P., Moore M., Ahmed A. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. Br J Cancer. 1984 Feb;49(2):161–172. doi: 10.1038/bjc.1984.28. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES